The UK National Institute of Clinical Excellence (NICE) have amended their prostate cancer guidelines and now recommend that the national standard for risk stratification for prostate cancer be based on […]
Archives for 2021
The BORS meeting will be held online as a virtual conference. The call for abstracts for the Annual Meeting is now open. The deadline for submission is 31st May 2021.
‘The research paves the way for cell therapies to treat liver disease – in other words, growing ‘mini-bile ducts’ in the lab as replacement parts that can be used to […]
The National Prostate Cancer Audit (NPCA) has published a short report on the use of the Cambridge-developed Cambridge Prognostic Groups for non-metastatic prostate cancer and its utility and benefit in […]